Elisenda Alsina-Sanchis
Overview
Explore the profile of Elisenda Alsina-Sanchis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fischer A, Alsina-Sanchis E
Curr Opin Cell Biol
. 2023 Nov;
86:102287.
PMID: 38029706
Growth of new blood vessels is considered requisite to cancer progression. Recent findings revealed that in addition to inducing angiogenesis, tumor-derived factors alter endothelial cell gene transcription within the tumor...
2.
Ovarian cancer relies on the PDGFRβ-fibronectin axis for tumorsphere formation and metastatic spread
Gendrau-Sanclemente N, Figueras A, Gracova K, Lahiguera A, Alsina-Sanchis E, Marin-Jimenez J, et al.
Mol Oncol
. 2023 Nov;
18(1):136-155.
PMID: 38010623
High-grade serous ovarian cancer (HGSOC) is the deadliest gynecological malignancy. The most common form of metastatic spread of HGSOC is transcoelomic dissemination. In this process, detached cells from the primary...
3.
Taylor J, Uhl L, Moll I, Hasan S, Wiedmann L, Morgenstern J, et al.
Nat Cancer
. 2023 Sep;
4(11):1544-1560.
PMID: 37749321
Cachexia is a major cause of morbidity and mortality in individuals with cancer and is characterized by weight loss due to adipose and muscle tissue wasting. Hallmarks of white adipose...
4.
Wiedmann L, De Angelis Rigotti F, Vaquero-Siguero N, Donato E, Espinet E, Moll I, et al.
Nat Commun
. 2023 Apr;
14(1):2353.
PMID: 37095087
Pancreatic ductal adenocarcinoma (PDAC) frequently metastasizes into the peritoneum, which contributes to poor prognosis. Metastatic spreading is promoted by cancer cell plasticity, yet its regulation by the microenvironment is incompletely...
5.
Alsina-Sanchis E, Mulfarth R, Moll I, Bohn S, Wiedmann L, Jordana-Urriza L, et al.
Cancer Res
. 2022 Oct;
82(23):4414-4428.
PMID: 36200806
Significance: Endothelial Notch signaling favors immunosuppression by increasing CXCL2 secretion to stimulate CD44 expression in macrophages, facilitating their education by tumor cells.
6.
Alsina-Sanchis E, Mulfarth R, Fischer A
Cancers (Basel)
. 2021 Jun;
13(11).
PMID: 34073394
Tumor progression, therapy resistance and metastasis are profoundly controlled by the tumor microenvironment. The contribution of endothelial cells to tumor progression was initially only attributed to the formation of new...
7.
Alsina-Sanchis E, Mulfarth R, Moll I, Mogler C, Rodriguez-Vita J, Fischer A
Mol Cancer Res
. 2020 Nov;
19(2):288-300.
PMID: 33139505
Oil is frequently used as a solvent to inject lipophilic substances into the peritoneum of laboratory animals. Although mineral oil causes chronic peritoneal inflammation, little is known whether other oils...
8.
Alsina-Sanchis E, Garcia-Ibanez Y, Figueiredo A, Riera-Domingo C, Figueras A, Matias-Guiu X, et al.
Arterioscler Thromb Vasc Biol
. 2018 Feb;
38(5):1216-1229.
PMID: 29449337
Objective: ALK1 (activin-receptor like kinase 1) is an endothelial cell-restricted receptor with high affinity for BMP (bone morphogenetic protein) 9 TGF-β (transforming growth factor-β) family member. Loss-of-function mutations in ALK1...
9.
Figueras A, Alsina-Sanchis E, Lahiguera A, Abreu M, Muinelo-Romay L, Moreno-Bueno G, et al.
Mol Cancer Ther
. 2017 Nov;
17(2):532-543.
PMID: 29146630
Epithelial ovarian cancer is characterized by a low recovery rate because the disease is typically diagnosed at an advanced stage, by which time most patients (80%) already exhibit disseminated neoplasia....
10.
Alsina-Sanchis E, Figueras A, Lahiguera A, Gil-Martin M, Pardo B, Piulats J, et al.
Int J Mol Sci
. 2017 Aug;
18(8).
PMID: 28758950
There have been no major improvements in the overall survival of ovarian cancer patients in recent decades. Even though more accurate surgery and more effective treatments are available, the mortality...